Cargando…

Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population

BACKGROUND: Previous population-based studies have described first primary breast cancer tumor characteristics and their association with contralateral breast cancer (CBC) risk. However, information on influential covariates such as treatment, family history of breast cancer, and BRCA1/2 mutation ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reiner, Anne S., Lynch, Charles F., Sisti, Julia S., John, Esther M., Brooks, Jennifer D., Bernstein, Leslie, Knight, Julia A., Hsu, Li, Concannon, Patrick, Mellemkjær, Lene, Tischkowitz, Marc, Haile, Robert W., Shen, Ronglai, Malone, Kathleen E., Woods, Meghan, Liang, Xiaolin, Morrow, Monica, Bernstein, Jonine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517810/ https://www.ncbi.nlm.nih.gov/pubmed/28724391 http://dx.doi.org/10.1186/s13058-017-0874-x

Ejemplares similares

Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
por: Langballe, Rikke, et al.
Publicado: (2016)

Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study
por: Sisti, Julia S., et al.
Publicado: (2015)

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
por: Brooks, Jennifer D., et al.
Publicado: (2018)

A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study
por: Brooks, Jennifer D., et al.
Publicado: (2020)

Mammographic texture features associated with contralateral breast cancer in the WECARE Study
por: Watt, Gordon P., et al.
Publicado: (2021)

The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study
por: Knight, Julia A., et al.
Publicado: (2018)

Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study
por: Lee, Sangkyu, et al.
Publicado: (2020)

Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case–control study of contralateral breast cancer risk in the WECARE Study
por: Brooks, Jennifer D., et al.
Publicado: (2013)

Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study
por: Teraoka, Sharon N, et al.
Publicado: (2011)

Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer
por: Brooks, Jennifer D., et al.
Publicado: (2016)

Risk for contralateral breast cancer among carriers of the CHEK2(*)1100delC mutation in the WECARE Study
por: Mellemkjær, L, et al.
Publicado: (2008)

Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE Study
por: Carlson, Lauren E., et al.
Publicado: (2021)

Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer
por: Watt, Gordon P., et al.
Publicado: (2019)

Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study
por: Bernstein, Jonine L, et al.
Publicado: (2004)

The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women
por: Larionov, Alexey, et al.
Publicado: (2023)

Statin use and risk of contralateral breast cancer: a nationwide cohort study
por: Langballe, Rikke, et al.
Publicado: (2018)

The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study
por: Bens, Annet, et al.
Publicado: (2020)

ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer
por: Bernstein, J L, et al.
Publicado: (2003)

Workshop on The Epidemiology of the ATM Gene: Impact on Breast Cancer Risk and Treatment, Present Status and Future Focus, Lillehammer, Norway, 29 June 2002
por: Bernstein, Jonine L, et al.
Publicado: (2002)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
por: Watt, Gordon P., et al.
Publicado: (2020)

Epidemiologic and molecular risk factors for contralateral breast cancer among young women
por: Li, C I, et al.
Publicado: (2003)

Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer
por: Begg, Colin B, et al.
Publicado: (2015)

Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy
por: Davies, Kalatu R, et al.
Publicado: (2015)

MRI evaluation of the contralateral breast in patients with recently diagnosed breast cancer
por: Taneja, Sangeeta, et al.
Publicado: (2012)

Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer
por: Kim, Hakyoung, et al.
Publicado: (2023)

MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2022)

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
por: Schaapveld, Michael, et al.
Publicado: (2007)

The impact of coding germline variants on contralateral breast cancer risk and survival
por: Morra, Anna, et al.
Publicado: (2023)

Contralateral breast dose from partial breast brachytherapy
por: Robinson, R. Cole, et al.
Publicado: (2015)

Adenomyoepithelioma of the Breast in the Setting of Prior Contralateral Breast Malignancy
por: Dauterman, Leah C, et al.
Publicado: (2023)

Only one breast remains at risk of contralateral cancer
por: Peto, R.
Publicado: (1987)

Risk of contralateral breast cancer in Denmark 1943-80.
por: Storm, H. H., et al.
Publicado: (1986)

Patterns of metastasis in women with metachronous contralateral breast cancer
por: Vichapat, V, et al.
Publicado: (2012)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Prediction and clinical utility of a contralateral breast cancer risk model
por: Giardiello, Daniele, et al.
Publicado: (2019)

The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty
por: Dogan, Lutfi, et al.
Publicado: (2011)

Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer
por: LI, ZHENG, et al.
Publicado: (2015)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Axillary metastasis from occult breast cancer and synchronous contralateral breast cancer initially suspected to be cancer with contralateral axillary metastasis: a case report
por: Song, Myung Won, et al.
Publicado: (2021)

Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
por: van Barele, Mark, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s9vjn2464jgocgq3pks2brspoi